Advertisement
Research Article| Volume 23, ISSUE 2, P159-168, January 15, 1988

Ketamine as a pharmacological model for tongue dyskinesia

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The purpose of this article is to document that ketamine hydrochloride, administered at an anesthetic dosage of about 100 mg/kg, produces tongue contractile activity in the rat. The methods for monitoring and quantitating ketamine-induced tongue contractions (KITCs) are described. We also found that neuroleptic agents consistently and readily abolish KITCs. On the basis of these observations and other pharmacological properties of ketamine, we propose that KITCs may be a useful model for studying neuroleptic-induced oral dyskinesia, e.g., tardive dyskinesia. Additional findings in support of this model are presented.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adams PM
        Interaction of phencyclidine with drugs affecting cholinergic neurotransmission.
        Neuropharmacology. 1980; 19: 151-153
        • Anis A
        • Berry SC
        • Burton NR
        • Lodge D
        The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methylaspartate.
        J Pharmacol. 1983; 79: 565-575
        • Baidessarini RJ
        • Tarsy D
        Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
        Annu Rev Neurosci. 1980; 3: 23-41
        • Basmajian JV
        • Stecko G
        A new bipolar electrode for electromyography.
        J Appl Physiol. 1962; 17: 849
        • Carlsson A
        • Lindquist M
        Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain.
        Acta Pharmacol Toxicol. 1963; 20: 140-144
        • Cohen ML
        • Chan SL
        • Trevor AJ
        In vitro inhibition of rat brain norepinephrine uptake and acetylcholinesterase by ketamine.
        in: Fed Proc. 82. 1973: 682
        • Cohen ML
        • Chan SL
        • Bhargava HN
        • Trevor AJ
        Inhibition of mammalian brain acetylcholinesterase by ketamine.
        Biochem Pharmacol. 1974; 23: 1647-1652
        • Corssen G
        • Domino EF
        Dissociative anesthesia: Further pharmacologie studies and first clinical experience with the phencyclidine derivative CI-581.
        Anesth Analg. 1966; 45: 29-40
        • Domino EF
        • Chodoff P
        • Corssen G
        Pharmacologie effects of CI-581, a new dissociative anesthetic, in man.
        Clin Pharmacol Ther. 1965; 6: 279-291
        • Fann WE
        • Wheless JC
        Neuropharmacology and aging: Mechanisms of movement disorders in the elderly.
        in: Palmer GC Neuropharmacology of Central Nervous System and Behavioral Disorders. Academic Press, Orlando, FL1981: 173-203
        • Fann WE
        • Lake CR
        • Gerber CJ
        • McKeizie GM
        Cholinergic suppression of tardive dyskinesia.
        Psychopharmacologia (Berl). 1974; 37: 101-107
        • Fessier RG
        • Sturgeon RD
        • Meltzer HY
        Phencyclidine induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra.
        Life Sci. 1979; 24: 1281-1288
        • Finck AD
        • Ngai SH
        Opiate receptor mediation of ketamine analgesia.
        Anesthesiology. 1982; 56: 291-297
        • Finnegan KT
        • Kanner MI
        • Meltzer HY
        Phencyclidine induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents.
        Pharmacol Biochem Behav. 1976; 5: 651-660
        • Garey RE
        • Heath RG
        The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalmic synaptosomes.
        Life Sci. 1976; 18: 1105-1110
        • Garey RE
        • McQuitty S
        • Tootle D
        • Heath RG
        The effects of apomorphine and haldol on PCP-induced behavioral and motor abnormalities in the rat.
        Life Sci. 1980; 26: 277-284
        • Gerlach J
        Tardive dyskinesia.
        Danish Med Bull. 1979; 26: 209-245
        • Johnson KM
        • Snell LD
        Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding.
        Pharmacol Biochem Behav. 1985; 22: 731-735
        • Johnson SW
        • Haroldsen PE
        • Hoffer BJ
        • Freedman R
        Presynaptic dopaminergic activity of phencyclidine in rat caudate.
        J Pharmacol Exp Ther. 1984; 229: 322-332
        • Klawans HL
        The pharmacology of tardive dyskinesia.
        Am J Psychiatry. 1973; 130: 82-85
        • Leavitt P
        • Moore RY
        Origin and organization of brainstem catecholamine innervation in the rat.
        J Comp Neurol. 1979; 186: 505-528
        • Lodge D
        • Anis NA
        • Burton NR
        Effects of optical isomers of ketamine on excitation of cat and rat sponal neutrones by amino acids and acetylcholine.
        Neurosci Lett. 1982; 29: 281-286
        • Lundy PM
        • Lockwood PA
        • Thompson G
        • Frew R
        Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms.
        Anesthesiology. 1986; 64: 359-363
        • Maayani S
        • Weinstein H
        • Ben-Zvi N
        • Cohen S
        • Sokolovsky M
        Psychotomimetics as anticholinergic agents—I.
        Biochem Pharmacol. 1974; 23: 1263-1281
        • Marietta MP
        • White PF
        • Pudwill CR
        • Way WL
        • Trevor AJ
        Biodisposition of ketamine in the rat: Self-induction of metabolism.
        J Pharmacol Exp Ther. 1976; 196: 536-544
        • Martin LL
        • Bouchai RL
        • Smith DJ
        Ketamine inhibits serotonin uptake in vivo.
        Neuropharmacology. 1982; 21: 113-118
        • McCarthy DA
        • Chen G
        • Kaump DH
        • Ensor C
        General anesthetic and other pharmacological properties of 2-(O-chlorphenyl)-2-methyl-amino cyclohexanone HCl (CI-581).
        J New Drugs. 1965; 5: 21-23
        • Miyosaka M
        • Domino EF
        Neuronal mechanisms of ketamine-induced anesthesia.
        Int J Neuropharmacol. 1968; 7: 557-573
        • Myslobodsky M
        • Ackermann RF
        • Mansour R
        • Golovchinsky V
        Ketamine-induced rotation and its interaction with naloxone in rats.
        Brain Res. 1979; 172: 191-195
        • Nabeshima T
        • Yamaguchi K
        • Hiramatsu M
        • Amano
        • Furukawa H
        • Kameyama T
        Serotonergic involvement in phencyclidine-induced behaviors.
        Pharmacol Biochem Behav. 1984; 21: 401-408
        • Palkovits M
        • Jacobovitz DM
        Topographic atlas of catecholamine and acetylcholinesterasecontaining neurons in the rat brain II. Hindbrain (mesencephalon, rhombencephalon).
        J Comp Neurol. 1974; 157: 29-42
        • Quirion R
        • Hammer Jr, RP
        • Herkenham M
        • Pert CB
        Phencyclidine (angel dust)/sigma “opiate” receptor: Visualization by tritium-sensitive film.
        in: Proc Natl Acad Sci USA. 78. 1981: 5881-5885
        • Raja SN
        • Guyenet PG
        Effects of phencyclidine on the spontaneous activity of monoaminergic neurons.
        Eur J Pharmacol. 1980; 63: 229-233
        • Richelson E
        Pharmacology and clinical considerations of neuroleptics.
        in: Palmer GC Neuropharmacology of Central Nervous System and Behavioral Disorders. Academic Press, Orlando, FL1981: 123-147
        • Schlemmer RF
        • Jackson JA
        • Preston KL
        • Bederka JP
        • Garver DL
        • Davis JM
        Phencyclidineinduced sterotyped behavior in monkeys: Antagonism by pimozide.
        Eur J Pharmacol. 1978; 52: 379-384
        • Smith DJ
        • Azzaro AJ
        • Jurndort H
        • Abbot SB
        The effect of ketamine HCl on the in vitro metabolism of norepinephrine in the rat cerebral cortex tissue.
        Neuropharmacology. 1975; 14: 473-487
        • Smith RC
        • Meltzer HY
        • Arora RC
        • Davis JM
        Effects of phencyclidine on 3H-catecholamines and 3H-serotonin uptake in synaptosomal preparations from rat brain.
        Biochem Pharmacol. 1977; 26: 1435-1439
        • Smith DJ
        • Azzaro AJ
        • Zaldivar SB
        • Parmer S
        • Lee HS
        The properties of optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines.
        Neuropharmacology. 1981; 20: 391-396
        • Smith DJ
        • Westfall DP
        • Adams JD
        Assessment of the potential agonistic and antagonistic properties of ketamine at opiate receptors in the guinea-pig ileum.
        Neuropharmacology. 1982; 21: 605-611
        • Steinbusch HWM
        Distribution of serotonin-immunoreactivity in the central nervous system of the rat—cell bodies and terminals.
        Neuroscience. 1981; 6: 557-618
        • Stavchansky S
        • Riffee W
        • Geary R
        Comparison between locomotor activity changes produced by phencyclidine and d-amphetamine in CD-1 male mice.
        Res Commun Chem Pathol Pharmacol. 1985; 48: 189-202
        • Sturgeon RD
        • Fessier RG
        • London SF
        • Meltzer HY
        A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
        Eur J Pharmacol. 1981; 76: 37-53
        • Taube HD
        • Monel H
        • Hand G
        • Starke K
        Phencyclidine and ketamine: Comparison with the effect of cocaine on the noradrenergic neurons of the rat brain cortex.
        Naunyn-Schmiedeberg Arch Pharmacol. 1975; 291: 47-54
        • Tsai M
        • Albuquerque EX
        • Aronstam RS
        • Eldefrawi AT
        • Eldefrawi MR
        • Triggle DJ
        Sites of action of phencyclidine-interactions with muscarinic receptors.
        Mol Pharmacol. 1980; 18: 179-184
        • Uhrbrand L
        • Faurbye A
        Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy.
        Psychopharmacologia. 1960; 1: 408-418
        • Vincent JP
        • Cavey D
        • Kamenka JM
        • Geneste P
        • Lazdundki M
        Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system.
        Brain Res. 1978; 152: 176-182
        • Warenycia MW
        • McKenzie GM
        Responses of striatal neurons to anesthetics and analgesics in freely moving rats.
        Gen Pharmacol. 1984; 15: 517-522